•
Mar 31, 2019

Jazz Pharmaceuticals Q1 2019 Earnings Report

Total Revenue
$508M
Previous year: $445M
+14.3%
EPS
$3.67
Previous year: $2.98
+23.2%
Gross Margin
93.3%
Gross Profit
$475M
Previous year: $411M
+15.6%
Cash and Equivalents
$547M
Previous year: $453M
+20.8%
Free Cash Flow
$194M
Total Assets
$5.28B
Previous year: $5.29B
-0.1%

Jazz Pharmaceuticals

Jazz Pharmaceuticals

Jazz Pharmaceuticals Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income